Pink SheetThe US Food and Drug Administration’s newly revised stand on testosterone labeling for cardiovascular risk is the visible tip of the metaphorical iceberg of years of effort that went into evaluating a
Pink SheetAfter another loss in the US Court of Appeals, Teva will seek a certiorari review by the US Supreme Court of its long-running inhaler patent case against Amneal . Teva had requested a full panel re
Generics BulletinTeva has suffered another nth blow in its long-running inhaler patent case against Amneal, as the US Court of Appeals for the Federal Circuit denied the Israeli firm’s request for an en banc reheari
Generics BulletinFormycon has received approval from the UK Medicines and Healthcare products Regulatory Agency for its FYB203 aflibercept biosimilar rival to Eylea, with the product approved under the name Ahzantive.